# Mereo Biopharma (MREO) — Analyst Forecast

MREO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mreo/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 19, 2026 | JP Morgan | Downgraded | Neutral → Underweight | — |
| Aug 11, 2026 | BTIG | Maintained | Buy | $1.00 |
| Aug 11, 2026 | Needham | Maintained | Buy | $3.00 |
| May 12, 2026 | BTIG | Maintained | Buy | $1.00 |
| Mar 23, 2026 | JP Morgan | Downgraded | Overweight → Neutral | — |
| Jan 16, 2026 | BTIG | Maintained | Buy | $1.00 |
| Jan 13, 2026 | Needham | Maintained | Buy | $3.00 |
| Dec 30, 2025 | Jefferies | Downgraded | Buy → Hold | $0.50 |
| Dec 29, 2025 | BTIG | Maintained | Buy | $1.00 |
| Dec 29, 2025 | LifeSci Capital | Downgraded | Outperform → Market Perform | — |
| Dec 22, 2025 | Needham | Maintained | Buy | $5.00 |
| Dec 18, 2025 | BTIG | Maintained | Buy | $6.00 |
| Aug 25, 2025 | JP Morgan | Maintained | Overweight | $8.00 |
| Jul 10, 2025 | Needham | Maintained | Buy | $5.00 |
| May 13, 2025 | Needham | Maintained | Buy | $7.00 |
| Apr 9, 2025 | Needham | Maintained | Buy | $7.00 |
| Mar 27, 2025 | JP Morgan | Initiated Coverage | Overweight | $7.00 |
| Mar 26, 2025 | Needham | Maintained | Buy | $7.00 |
| Mar 18, 2025 | Cantor Fitzgerald | Maintained | Overweight | $7.00 |
| Jan 13, 2025 | Needham | Maintained | Buy | $7.00 |

## Frequently Asked Questions

### What is the latest analyst rating on MREO?

On Aug 19, 2026, JP Morgan downgraded Mereo Biopharma to Underweight.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).